Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Keymed Biosciences Inc.: Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...
Mexico News Daily19h
US to pursue ‘total elimination of cartels;’ Sheinbaum says they should start at home
Mexican President Sheinbaum responded to the the U.S. government's plan for "total elimination of Cartels” on Friday.
Le Lézard15h
Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence
Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Matt Coffey, Ph.D., President and Chief Executive Officer, will not return ...
Le Lézard16h
19 Mercy Medical Center in Baltimore Physicians Named Castle Connolly's "Top Doctors" for 2025
A total of 19 physicians at Mercy Medical Center representing 11 different specialties have been named "Top Doctors" by Castle Connolly Medical Ltd. "Mercy providers continue to earn accolades for ...